pancuronium has been researched along with Muscular-Atrophy* in 6 studies
6 other study(ies) available for pancuronium and Muscular-Atrophy
Article | Year |
---|---|
Pancuronium-induced prolonged neuromuscular blockade.
Topics: Adult; Aged; Clinical Protocols; Diagnosis, Differential; Drug Synergism; Electromyography; Exercise Therapy; Female; Humans; Hypnotics and Sedatives; Infant, Newborn; Infusions, Intravenous; Male; Middle Aged; Monitoring, Physiologic; Muscular Atrophy; Neural Conduction; Pancuronium; Paralysis; Physical Therapy Modalities | 1991 |
Hydrocortisone and pancuronium bromide: acute myopathy during status asthmaticus.
Topics: Asthma; Female; Humans; Hydrocortisone; Middle Aged; Muscular Atrophy; Pancuronium; Status Asthmaticus | 1988 |
Disuse atrophy in a ventilated patient with status asthmaticus receiving neuromuscular blockade.
Topics: Adult; Asthma; Female; Humans; Muscular Atrophy; Neuromuscular Junction; Pancuronium; Respiration, Artificial; Respiratory Care Units; Status Asthmaticus; Time Factors | 1987 |
Skeletal muscle growth failure induced in premature newborn infants by prolonged pancuronium treatment.
Topics: Autopsy; Humans; Infant, Newborn; Male; Muscles; Muscular Atrophy; Muscular Diseases; Pancuronium; Respiratory Distress Syndrome, Newborn | 1986 |
Neuromuscular complications in patients given Pavulon (pancuronium bromide) during artificial ventilation.
This paper reports on 12 patients in a 3-year period (from 1st July 1980 to 1st July 1983) who were treated with artificial ventilation and with the muscle relaxant pancuronium bromide (Pavulon), over a period of 6 days or longer. After discontinuation of this drug these patients developed severe tetraparesis with areflexia, sometimes combined with disturbances of the extraocular and facial muscles and diffuse muscular atrophy, without sensory disturbances. Seven patients recovered completely after 2-5 months, two made an incomplete recovery and three died due to the primary disease. It is suggested that these neuromuscular complications were caused by prolonged high-dosage Pavulon treatment in combination with renal and hepatic disturbances and/or the use of aminoglucosides. Topics: Adult; Aged; Electromyography; Humans; Middle Aged; Muscles; Muscular Atrophy; Nerve Fibers, Myelinated; Neuromuscular Diseases; Pancuronium; Respiration, Artificial | 1985 |
Amyotonia congenita.
Topics: Anesthesia, Intravenous; Child; Child, Preschool; Female; Humans; Male; Muscular Atrophy; Neuromuscular Diseases; Pancuronium; Postoperative Care; Preoperative Care; Succinylcholine | 1974 |